An Open-Label Study of Azetukalner in Major Depressive Disorder
An Open-Label Study of Azetukalner in Major Depressive Disorder
Enrolling by invitation · NCT06922110 · Registry updated 2026-09-03Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| An Open-Label Study of Azetukalner in Major Depressive Disorder | depressive disorder, major depressive disorder, mood disorder, psychiatric disorder | Enrolling by invitation | Phase 3 | 2026-09-03 | NCT06922110 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Xenon Pharmaceuticals Inc. | 9 |
69 results · Page 1 of 3
Research sites
Swipe the table sideways for more columns.